Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 162 (2 Pt B), 222-8

Mesenchymal Stem Cells Ameliorate Experimental Autoimmune Hepatitis by Activation of the Programmed Death 1 Pathway

Affiliations

Mesenchymal Stem Cells Ameliorate Experimental Autoimmune Hepatitis by Activation of the Programmed Death 1 Pathway

Yi Chen et al. Immunol Lett.

Abstract

Previous studies have shown beneficial effects of mesenchymal stem cells (MSCs) transplantation in many autoimmune diseases. However, few studies have focused on the effects of MSCs on autoimmune hepatitis. In our study, we investigated the therapeutic effects of BMSCs (bone mesenchymal stem cells) transplantation in mouse experimental autoimmune hepatitis (EAH) and explored the potential mechanism. BMSCs were injected intravenously into EAH mice. Then, serum levels of ALT and AST, and pathologic alteration of liver tissue were measured to evaluate the liver function and inflammation degree. The expressions of programmed death ligand 1, IL-17 and IL-23 were detected by enzyme-linked immunosorbent assay (ELISA), reverse transcription-polymerase chain reaction (RT-PCR), and western blotting. Upon serum biochemical levels and pathological examination, the BMSCs-treated mice especially with multiple dosing administration showed significantly reduction of liver damage. Moreover, the expression of IL-17 was down-regulated by BMSCs intervention as compared to the model group, whereas the PD-L1 and IL-23 were up-regulated following the administration of MSCs. In conclusion, the results of this study suggest that BMSCs transplantation, especially on multiple dosing, may exert immunosuppression effect to ameliorate EAH through the inhibition of IL-17 and up-regulation of PD-L1.

Keywords: Autoimmune hepatitis; Interleukin-17; Interleukin-23; Mesenchymal stem cells; Programmed death ligand 1.

Similar articles

See all similar articles

Cited by 6 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback